Mpox & Other Infectious Disease Testing Oligos
In August 2024 the WHO Director-General declared the Mpox outbreak a public health emergency of international concern.
As with the SARS-CoV-2 Pandemic, Biolegio stands ready to support Clinical researchers and the Molecular Diagnostic testing industry with their Oligo requirements with custom scales, fast-turnaround, and the quality and tracebility needed.
Discover More about how our Custom Service Solutions can assist with all your Clinical Testing and Molecular Diagnostic Production requirements including Mpox Primers and Probes